{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:41:58Z","timestamp":1790476918137,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012120","name":"Ontario Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012171","name":"Ontario Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.pnpbp.2025.111315","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:58:31Z","timestamp":1741175911000},"page":"111315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pharmacogenetics of obsessive-compulsive disorder: Investigations of intragenic and regulatory region genetic variations"],"prefix":"10.1016","volume":"138","author":[{"given":"Gwyneth","family":"Zai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Zai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa F.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111315_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jcpt.12766","article-title":"Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder","volume":"44","author":"Abdolhosseinzadeh","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1037\/pha0000297","article-title":"BDNF association study with obsessive-compulsive disorder, its clinical characteristics, and response to fluvoxamine-treatment in Iranian patients","volume":"28","author":"Abdolhosseinzadeh","year":"2020","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1126\/science.1116502","article-title":"Sequence variants in SLITRK1 are associated with Tourette's syndrome","volume":"310","author":"Abelson","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0025","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"2013"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jocn.2009.08.020","article-title":"The association between personality, pain threshold and a single nucleotide polymorphism (rs3813034) in the 3\u2032-untranslated region of the serotonin transporter gene (SLC6A4)","volume":"17","author":"Aoki","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111315_bib448","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1044-7431(03)00129-5","article-title":"Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth","volume":"24","author":"Aruga","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111315_bib446","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-1119(03)00715-7","article-title":"Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue","volume":"315","author":"Aruga","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/appi.ajp.2009.08081251","article-title":"Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children","volume":"166","author":"Barnett","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomics testing in psychiatry","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0045","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gr.137323.112","article-title":"Annotation of functional variation in personal genomes using RegulomeDB","volume":"22","author":"Boyle","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0050","first-page":"176","article-title":"Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder","volume":"14","author":"Brandl","year":"2014","journal-title":"Pharm. J."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0055","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1093\/hmg\/ddz161","article-title":"A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity","volume":"28","author":"Bratfield","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41398-020-01121-9","article-title":"Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder","volume":"11","author":"Burton","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v101.i01","article-title":"The poolr package for combining independent and dependent p values","volume":"101","author":"Cinar","year":"2022","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10524","article-title":"Temporal dynamics and genetic control of transcription in the human prefrontal cortex","volume":"478","author":"Colantuoni","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.223","article-title":"Obsessive-compulsive symptoms in a large population-based twin-family sample are predicted by clinically based polygenic scores and by genome-side SNPs","volume":"6","author":"den Braber","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4088\/JCP.v68n0512","article-title":"Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial","volume":"68","author":"Denys","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.comppsych.2005.11.006","article-title":"Impact of obsessive-compulsive disorder on quality of life","volume":"47","author":"Eisen","year":"2006","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0090","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jpsychires.2013.03.007","article-title":"Independent effects of 5\u2032 and 3\u2032 functional variants in the serotonin transporter gene on suicidal behavior in the context of childhood trauma","volume":"47","author":"Enoch","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112272","article-title":"The potential impact of COMT gene variants on dopamine regulation and phenotypic traits of ASD patients","volume":"378","author":"Esmaiel","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ajmg.b.32184","article-title":"Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research","volume":"162B","author":"Fabbri","year":"2013","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1471-4159.2007.04767.x","article-title":"Lifeguard\/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment","volume":"103","author":"Fernandez","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1461145704004675","article-title":"Evidence-based pharmacotherapy of obsessive-compulsive disorder","volume":"8","author":"Fineberg","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0115","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version (SCID-I\/P)","author":"First","year":"1996"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0120","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pneurobio.2014.07.003","article-title":"Imaging genetics in obsessive-compulsive disorder: linking genetic variations to alterations in neuroimaging","volume":"121","author":"Grunblatt","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/14622416.10.3.385","article-title":"Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment","volume":"10","author":"Gupta","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2009.10.015","article-title":"Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder","volume":"67","author":"Gyawali","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0140","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41593-021-00876-8","article-title":"Exome sequencing in obsessive-compulsive disorder reveals a burden of rare damaging coding variants","volume":"24","author":"Halvorsen","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0145","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1073\/pnas.1202044109","article-title":"Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory","volume":"109","author":"Hartley","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0150","doi-asserted-by":"crossref","DOI":"10.1017\/S0016672315000099","article-title":"Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders","volume":"97","author":"Hess","year":"2015","journal-title":"Genet. Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ajmg.b.31249","article-title":"Association of SNPs linked to increased expression of SLC1A1 with schizophrenia","volume":"159B","author":"Horiuchi","year":"2012","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/da.20506","article-title":"Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls","volume":"26","author":"Huppert","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0165","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/mp.2017.154","article-title":"Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis","volume":"23","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0170","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/mp.2013.13","article-title":"The ENCODE project: implications for psychiatric genetics","volume":"18","author":"Kavanagh","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0175","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2659","article-title":"Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorder","volume":"33","author":"Lisoway","year":"2018","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0185","article-title":"Variant-to-function analysis of the childhood obesity chr12q13 locus implicates rs7132908 as a casual variant within the 3\u2019 UTR of FAIM2","volume":"4","author":"Littleton","year":"2024","journal-title":"Cell. Genom."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0190","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2147\/TCRM.S225536","article-title":"Functional BDNF rs7124442 variant regulated by miR-922 is associated with better short-term recovery of ischemic stroke","volume":"15","author":"Liu","year":"2019","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0195","article-title":"The role of SliTrk5 in central nervous system","volume":"2022","author":"Liu","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2019.05.025","article-title":"Antidepressant pharmacogenetics in children and young adults: a systematic review","volume":"254","author":"Maruf","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/gbb.12128","article-title":"Role of GAD2 and HTR1B genes in early-onset obsessive-compulsive disorder: results from transmission disequilibrium study","volume":"13","author":"Mas","year":"2014","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/mp.2014.43","article-title":"Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS","volume":"20","author":"Mattheisen","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0215","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1601-183X.2007.00301.x","article-title":"Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia","volume":"6","author":"Mercader","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1590\/S0004-282X2011000300003","article-title":"Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment","volume":"69","author":"Miguita","year":"2011","journal-title":"Arq. Neuropsiquiatr."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111315_bib447","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/dnares\/5.6.355","article-title":"Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro","volume":"5","author":"Nagase","year":"1998","journal-title":"DNA Res"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1192\/bjp.bp.113.127191","article-title":"ENCODE and a new landscape for psychiatric genetics","volume":"203","author":"Nair","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/JCP.0000000000000454","article-title":"Polymorphism of rs3813034 in serotonin transporter gene SLC6A4 is associated with the selective serotonin and serotonin-norepinephrine reuptake inhibitor response in depressive disorder: sequencing analysis of SLC6A4","volume":"36","author":"Nonen","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1461145702002900","article-title":"Treatment non-response in OCD: methodological issues and operational definitions","volume":"5","author":"Pallanti","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0240","first-page":"361","article-title":"Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population","volume":"50","author":"Pap","year":"2009","journal-title":"Corat. Med. J."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0245","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ajmg.b.32098","article-title":"Genetic variants in the catechol-o-methyltransferase gene are associated with impulsivity and executive function: relevance for major depression","volume":"159B","author":"Pap","year":"2012","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111315_bb0250","first-page":"285","article-title":"Association between the COMT gene and rumination in a Hungarian sample","volume":"14","author":"Pap","year":"2012","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.31887\/DCNS.2010.12.2\/dpauls","article-title":"The genetics of obsessive-compulsive disorder: a review","volume":"12","author":"Pauls","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0260","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0265","article-title":"Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia","volume":"10","author":"Perkovic","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jocrd.2015.06.004","article-title":"A preliminary candidate gene study in body dysmorphic disorder","volume":"6","author":"Phillips","year":"2015","journal-title":"J. Obsessive. Compuls. Relat. Disord."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0275","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a toolset for whole-genome association and population-based linkage analysis","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0280","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mp.2015.32","article-title":"Whole-genome association analysis of treatment response in obsessive-compulsive disorder","volume":"21","author":"Qin","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0285","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpsychires.2024.03.044","article-title":"An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: a systematic review and individual-patient data meta-analysis","volume":"173","author":"Ramakrishnan","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0290","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.biopsych.2009.05.017","article-title":"A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder","volume":"66","author":"Real","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0295","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1523\/JNEUROSCI.2188-10.2011","article-title":"Fas\/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia","volume":"31","author":"Reich","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0300","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1038\/s41380-023-01998-0","article-title":"Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs","volume":"28","author":"Roseberry","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"Database issue","key":"10.1016\/j.pnpbp.2025.111315_bb0305","first-page":"D56","article-title":"ENCODE data in the UCSC genome browser: year 5 update","volume":"41","author":"Rosenbloom","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0310","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuropsychologia.2007.10.009","article-title":"Planning, decision-making and the COMT rs4818 polymorphism in healthy males","volume":"46","author":"Roussos","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0320","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/genes14071358","article-title":"Genotypic and haplotypic association of catechol-O-methyltransferase rs4680 and rs4818 gene polymorphisms with particular clinical symptoms in schizophrenia","volume":"14","author":"Sagud","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0325","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1210\/clinem\/dgac718","article-title":"A genetic assessment of dopamine agonist-induced impulse control disorder in patients with prolactinoma","volume":"108","author":"Sahin","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1755-5949.2009.00130.x","article-title":"Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: a family-based study","volume":"17","author":"Sampaio","year":"2011","journal-title":"C.N.S. Neurosci. Ther."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0335","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.2125","article-title":"Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice","volume":"16","author":"Shmelkov","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/YCO.0000000000000023","article-title":"Antidepressant pharmacogenetics","volume":"27","author":"Singh","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0345","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neubiorev.2017.05.029","article-title":"A review of the role of serotonin system genes in obsessive-compulsive disorder","volume":"80","author":"Sinopoli","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0350","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.96.22.12667","article-title":"LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death","volume":"96","author":"Somia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0355","article-title":"Rare synaptogenesis-impairing mutations in SLITRK5 are associated with obsessive compulsive disorder","volume":"12","author":"Song","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0360","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/mp.2012.85","article-title":"Genome-wide association study of obsessive-compulsive disorder","volume":"18","author":"Stewart","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0365","article-title":"Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci","author":"Strom","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0370","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/mp.2012.76","article-title":"Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0375","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00702-009-0229-6","article-title":"Pharmacogenetics of anxiolytic drugs","volume":"116","author":"Tiwari","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0385","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ajmg.b.32092","article-title":"Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder","volume":"159B","author":"Tukel","year":"2012","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0390","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1375\/twin.8.5.450","article-title":"Twin studies on obsessive-compulsive disorder: a review","volume":"8","author":"Van Grootheest","year":"2005","journal-title":"Twin Res. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0395","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/13651501.2011.653375","article-title":"Catechol-O-methyltransferase gene expression is associated with response to citalopram in obsessive-compulsive disorder","volume":"16","author":"Vulink","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0400","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jad.2017.12.010","article-title":"HTR1A\/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients","volume":"228","author":"Wang","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"Database issue","key":"10.1016\/j.pnpbp.2025.111315_bb0405","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0410","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0415","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s00018-012-1022-5","article-title":"What model organisms and interactomics can reveal about the genetics of human obesity","volume":"69","author":"Williams","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0420","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1479164114565630","article-title":"Promoter methylation of fas apoptotic inhibitory molecule 2 gene is associated with obesity and dyslipidaemia in Chinese children","volume":"12","author":"Wu","year":"2015","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0425","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12888-018-1849-x","article-title":"Polymorphisms in the human serotonin receptor 1B (HTR1B) gene are associated with schizophrenia: a case control study","volume":"18","author":"Xia","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111315_bb0430","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12888-020-02906-4","article-title":"Functional polymorphisms and transcriptional analysis in the 5\u2032 region of the human serotonin receptor 1B gene (HTR1B) and their associations with psychiatric disorders","volume":"20","author":"Xia","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"Web Server issue","key":"10.1016\/j.pnpbp.2025.111315_bb0435","doi-asserted-by":"crossref","first-page":"W600","DOI":"10.1093\/nar\/gkp290","article-title":"SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies","volume":"37","author":"Xu","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0440","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/7854_2020_205","article-title":"Pharmacogenetics of obsessive-compulsive disorder: an evidence-update","volume":"49","author":"Zai","year":"2021","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111315_bb0445","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2217\/pgs.14.83","article-title":"Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for the clinicians","volume":"15","author":"Zai","year":"2014","journal-title":"Pharmacogenomics"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:26:06Z","timestamp":1762284366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":90,"alternative-id":["S0278584625000697"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111315","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenetics of obsessive-compulsive disorder: Investigations of intragenic and regulatory region genetic variations","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111315"}}